September 1, 2017 Quantitative measurements reveal elevated levels of HER2-HER3 heterodimers in brain metastases compared to matched primary breast cancers Read more »
November 1, 2017 Runs of Homozygosity (ROH) reveal that segmental-UPD occurs as a result of recombination mediated repair of genomic imbalance Read more »
November 1, 2017 Epi proColon®, Septin 9 gene methylation detection assay as a screening tool for colorectal cancer Read more »
November 1, 2017 Unique 9q34 rearrangements in T-ALL: Elucidation and characterization by microarray analysis, RNA sequencing and FISH Read more »
November 1, 2017 EGFR gene mutation analysis in non-small cell lung cancer using cobas® assay in FFPE and plasma specimen types Read more »
November 1, 2017 Acute promyelocytic leukemia with atypical karyotype and FLT3-ITD mutation is associated with inferior clinical outcome Read more »
November 1, 2017 Utilization of peripheral blood for diagnostic testing for MDS/MPN patients: Efficacy and benefits of an SNP microarray analysis Read more »
March 1, 2018 p95HER2 Methionine 611 Carboxy-Terminal fragment is predictive of Trastuzumab adjuvant treatment benefit in the FinHer trial Read more »
March 1, 2018 High p95HER2/HER2 ratio associated with poor outcome in Trastuzumab-treated HER2-positive metastatic breast cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance) Read more »
April 1, 2018 Epi proColon®: Use of a non-invasive SEPT9 gene methylation blood test for colorectal cancer screening: A national laboratory experience Read more »
